World's Best Scientists 2026 revealed!
Tibor Schuster

Tibor Schuster

D-Index & Metrics

Medicine

D-Index
84
Citations
25376
World Ranking
15122
National Ranking
626

Overview

Tibor Schuster is a researcher affiliated with McGill University in Canada specializing in Medicine, with a significant focus on several subfields including General Health Professions, Cardiology and Cardiovascular Medicine, Epidemiology, Public Health, Environmental and Occupational Health, and Infectious Diseases.

Their work commonly addresses topics such as:

  • Cardiac Valve Diseases and Treatments
  • Mobile Health and mHealth Applications
  • Cardiovascular Function and Risk Factors
  • Healthcare Systems and Technology
  • Cultural Competency in Health Care
  • Health Systems, Economic Evaluations, Quality of Life
  • HIV/AIDS Research and Interventions

Some of the notable recent papers authored or co-authored by Schuster include:

  • "Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review" published in 2024 in the Journal of Medical Internet Research
  • "A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding study" published in 2021 in The Lancet Microbe
  • "Subphenotyping of Patients With Aortic Stenosis by Unsupervised Agglomerative Clustering of Echocardiographic and Hemodynamic Data" published in 2021 in JACC: Cardiovascular Interventions
  • "Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study" published in 2022 in BMJ Open
  • "Excess body weight as a predictor of response to treatment with antidepressants in patients with depressive disorder" published in 2020 in Journal of Affective Disorders

Frequent co-authors collaborating with Schuster include:

  • Stephanie Long
  • Kim Engler
  • Bertrand Lebouché
  • Mark Lachmann
  • Elena Rippen

Their research has been published repeatedly in well-regarded venues such as The Annals of Family Medicine, F1000Research, BMJ Open, SSRN Electronic Journal, and Journal of Medical Internet Research.

Best Publications

  • Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

    Sonja Gillen;Tibor Schuster;Christian Meyer zum Büschenfelde;Helmut Friess

  • Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS): an international multicentre, randomised controlled trial

    Andrew J Davidson;Nicola Disma;Jurgen C de Graaff;Davinia E Withington

  • PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

    Florian Lordick;Katja Ott;Bernd-Joachim Krause;Wolfgang A Weber

  • Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement

    Dirk Sibbing;Werner Koch;Daniela Gebhard;Tibor Schuster

  • Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery.

    Norbert Hüser;Christoph W. Michalski;Mert Erkan;Tibor Schuster

  • Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review.

    T. Reuther;T. Schuster;U. Mende;A. Kübler

  • The detection rate of [11C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

    B. J. Krause;M. Souvatzoglou;M. Tuncel;K. Herrmann

  • Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period.

    Robert Rosenberg;Jan Friederichs;Tibor Schuster;Ralf Gertler

  • Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

    S. Lorenzen;T. Schuster;R. Porschen;S.-E. Al-Batran

  • Mucinous and Signet-Ring Cell Colorectal Cancers Differ from Classical Adenocarcinomas in Tumor Biology and Prognosis

    Ulrich Nitsche;Anina Zimmermann;Christoph Späth;Tara Müller

  • Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period

    Stefanie Schulz;Tibor Schuster;Julinda Mehilli;Robert A Byrne

  • Evaluation of the Novel Myocardial Perfusion Positron-Emission Tomography Tracer 18F-BMS-747158-02 Comparison to 13N-Ammonia and Validation With Microspheres in a Pig Model

    S.G. Nekolla;S. Reder;A. Saraste;T. Higuchi

  • 72-h kinetics of high-sensitive troponin T and inflammatory markers after marathon.

    Johannes Scherr;Siegmund Braun;Tibor Schuster;Charlotte Hartmann

  • Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

    Gjin Ndrepepa;Tibor Schuster;Martin Hadamitzky;Robert A. Byrne

  • Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

    F Lordick;B Luber;S Lorenzen;S. Hegewisch-Becker

  • Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid.

    S. M. Kagerbauer;J. Martin;T. Schuster;M. Blobner

  • Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002.

    Sébastien Couraud;Felipe Vaca-Paniagua;Felipe Vaca-Paniagua;Stéphanie Villar;Javier Oliver

  • Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer

    M. Kranzfelder;T. Schuster;H. Geinitz;H. Friess

  • TFAP2E–DKK4 and Chemoresistance in Colorectal Cancer

    Matthias P.A. Ebert;Marc Tänzer;Benjamin Balluff;Elke Burgermeister

  • (18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.

    Christian Meyer zum Büschenfelde;Ken Herrmann;Tibor Schuster;Hans Geinitz

Frequent Co-Authors

Ken Herrmann
Ken Herrmann German Cancer Research Center
Markus Schwaiger
Markus Schwaiger Technical University of Munich
Robert D. Rosenberg
Robert D. Rosenberg Technical University of Munich
Christian Peschel
Christian Peschel Technical University of Munich
Roland M. Schmid
Roland M. Schmid Technical University of Munich
Heinz Höfler
Heinz Höfler Technical University of Munich
Axel Walch
Axel Walch Technical University of Munich
Hans-Jürgen Wester
Hans-Jürgen Wester Technical University of Munich
Adnan Kastrati
Adnan Kastrati Technical University of Munich
Florian Lordick
Florian Lordick Leipzig University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens the door to various related fields and modern educational options. Many students now consider accelerated healthcare programs to fast-track their entry into leadership or administrative roles in healthcare. These programs often offer flexible online learning, allowing you to balance your career and studies effectively.

For registered nurses looking to advance, adn to msn bridge programs provide a streamlined pathway to higher qualifications and more specialized roles. If your interest lies in nutrition and health, pursuing the best online food science degree unlocks career options in wellness, research, and dietetics.

Accreditation is essential when selecting a program. To ensure your credentials are valued by employers, focus on which online healthcare degree programs are recognized for their accreditation by cahme? Choosing a CAHME-accredited Master of Healthcare Administration or similar programs can be a smart investment in your future in healthcare leadership.

Best Scientists Citing Tibor Schuster

Trending Scientists